Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioannis Karfis

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Opinion in Oncology|October 23, 2020
131I-metaiodobenzylguanidine and peptide receptor radionuclide therapy in pheochromocytoma and paragangliomaChristiane Jungels, Ioannis Karfis
Current Opinion in Oncology|June 29, 2021
Targeted radionuclide therapy: an emerging field in solid tumoursCarlos Artigas, Magdalena Mileva, Patrick Flamen, et al.
Current Opinion in Oncology|June 4, 2026
Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumoursZahra Noordally, Magdalena Mileva, Alain Hendlisz, et al.
World Journal of Nuclear Medicine|October 27, 2021
Everolimus-induced somatostatin receptor overexpression in a rectal neuroendocrine tumor patient may promote somatostatin receptor-guided radionuclide therapy (peptide receptor radiotherapy) as an additional treatment optionMagdalena Mileva, Zéna Wimana, Patrick Flamen, et al.
Clinical Nuclear Medicine|June 28, 2019
Low 68Ga-PSMA PET/CT Uptake in Chronic Intramuscular Nodular FasciitisNicolas Plouznikoff, Carlos Artigas, Ioannis Karfis, et al.
Clinical Nuclear Medicine|May 16, 2018
Acute Pancreatitis Following Peptide Receptor Radionuclide Therapy: An Unusual Adverse EventIoannis Karfis, Gwennaëlle Marin, Godelieve Machiels, et al.
Hellenic Journal of Nuclear Medicine|December 11, 2020
How COVID-19 pandemic affected cancer progression: Three different scenarios evidenced by PET imagingMagdalena Mileva, Carlos Artigas, Geraldine Gebhart, et al.
Nuclear Medicine and Biology|April 11, 2021
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [<sup>177</sup>Lu]Lu-DOTATATE in a panel of cancer cell linesWendy Delbart, Ghanem E Ghanem, Ioannis Karfis, et al.
Hellenic Journal of Nuclear Medicine|June 29, 2012
Myocardial bridge: an unusual cause of asymptomatic ST-elevation during treadmill stress test causing functional ischaemiaIoannis Karfis, Christos Dresios, Irini Kotsalou, et al.
EJNMMI Reports|January 22, 2026
A case report of enduring benefit of sequential PRRT in malignant insulinomaCristina-An Wang Zhang, Natacha Driessens, Magdalena Mileva, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Oncology|October 23, 2020
131I-metaiodobenzylguanidine and peptide receptor radionuclide therapy in pheochromocytoma and paragangliomaChristiane Jungels, Ioannis Karfis
Current Opinion in Oncology|June 29, 2021
Targeted radionuclide therapy: an emerging field in solid tumoursCarlos Artigas, Magdalena Mileva, Patrick Flamen, et al.
Current Opinion in Oncology|June 4, 2026
Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumoursZahra Noordally, Magdalena Mileva, Alain Hendlisz, et al.
World Journal of Nuclear Medicine|October 27, 2021
Everolimus-induced somatostatin receptor overexpression in a rectal neuroendocrine tumor patient may promote somatostatin receptor-guided radionuclide therapy (peptide receptor radiotherapy) as an additional treatment optionMagdalena Mileva, Zéna Wimana, Patrick Flamen, et al.
Clinical Nuclear Medicine|June 28, 2019
Low 68Ga-PSMA PET/CT Uptake in Chronic Intramuscular Nodular FasciitisNicolas Plouznikoff, Carlos Artigas, Ioannis Karfis, et al.
Clinical Nuclear Medicine|May 16, 2018
Acute Pancreatitis Following Peptide Receptor Radionuclide Therapy: An Unusual Adverse EventIoannis Karfis, Gwennaëlle Marin, Godelieve Machiels, et al.
Hellenic Journal of Nuclear Medicine|December 11, 2020
How COVID-19 pandemic affected cancer progression: Three different scenarios evidenced by PET imagingMagdalena Mileva, Carlos Artigas, Geraldine Gebhart, et al.
Nuclear Medicine and Biology|April 11, 2021
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [<sup>177</sup>Lu]Lu-DOTATATE in a panel of cancer cell linesWendy Delbart, Ghanem E Ghanem, Ioannis Karfis, et al.
Hellenic Journal of Nuclear Medicine|June 29, 2012
Myocardial bridge: an unusual cause of asymptomatic ST-elevation during treadmill stress test causing functional ischaemiaIoannis Karfis, Christos Dresios, Irini Kotsalou, et al.
EJNMMI Reports|January 22, 2026
A case report of enduring benefit of sequential PRRT in malignant insulinomaCristina-An Wang Zhang, Natacha Driessens, Magdalena Mileva, et al.
Pageof 4